{
    "Trade/Device Name(s)": [
        "Dimension Vista\u2122 Free Thyroxine Flex\u00ae reagent cartridge (FT4)",
        "Dimension Vista\u2122 LOCI 1 Calibrator"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K053531",
    "Predicate Device Reference 510(k) Number(s)": [
        "K970389"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEC",
        "JIT"
    ],
    "Summary Letter Date": "March 3, 2006",
    "Summary Letter Received Date": "December 19, 2005",
    "Submission Date": "December 16, 2005",
    "Regulation Number(s)": [
        "21CFR862.1695",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Free thyroxine test system",
        "Calibrator, Secondary"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Free Thyroxine (FT4)",
        "Free Triiodothyronine (FT3)",
        "Thyroid Stimulating Hormone (TSH)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Luminescent Oxygen Channeling Immunoassay (LOCI)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent cartridge",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista Free Thyroxine Flex reagent cartridge and LOCI 1 Calibrator for measurement and calibration of thyroid analytes using LOCI chemiluminescent immunoassay technology.",
    "Indications for Use Summary": "Quantitative measurement of free thyroxine in human serum and plasma and calibration for measurement of FT4, FT3, and TSH in human specimens for diagnosis and treatment of thyroid disease.",
    "fda_folder": "Clinical Chemistry"
}